tirzepatide downsides 20 Possible Side Effects Long-Term to Be Aware Of Tirzepatide vs. Semaglutide: What You

This switch should always be managed by a healthcare professional

Why Blood Sugar May Not Be Very High In classic DKA: Insulin deficiency severe hyperglycemia In euglycemic DKA: Some insulin is still being administered Blood glucose may appear only mildly elevated But insulin is insufficient to prevent ketogenesis This can delay recognition because: Patients and clinicians may not suspect DKA with glucose under 250 mg/dL Symptoms may initially resemble dehydration or GI illness Additional Contributing Factors GLP-1 use in Type 1 diabetes may also increase DKA risk due to: Vomiting dehydration stress hormones ketone rise Intentional insulin reduction due to fear of hypoglycemia Reduced basal insulin during weight loss Increased glycemic variability from delayed gastric emptying Hypoglycemia and the Insulin Reduction Trap Another issue is the cycle that can develop: Appetite decreases Insulin dose is reduced Hypoglycemia occurs intermittently Insulin is reduced further Ketone production increases Over time, this can push the patient into metabolic instability

Regarding timing, regenerative treatments can be initiated in the early stages, even during ongoing weight loss

This is an anatomical feature where blood vessels at the optic nerve head are tightly packed together

While this test doesn't predict pain tolerance, understanding your genetic predispositions helps your provider optimize your tirzepatide dose and manage side effects proactively